Injective
Why Injective is up 1.1% in the last hour
Analysis
Injective (INJ) rose 1.1% over the past hour, likely supported by renewed attention after Cointelegraph highlighted comments from Injective’s CEO about the “tug-of-war” between decentralization and scalability as Layer-1 adoption grows. The coverage may have boosted near-term sentiment and visibility around Injective’s positioning in the L1 landscape, contributing to modest buying pressure.
Contributing Factors (1)
L1s face decentralization 'tug-of-war' as adoption grows: Injective CEO
Blockchains will face increasing pressure to compromise on decentralization to meet user demand for speed and scalability, Injective CEO Eric Chen said.
Move Details
Explanation Confidence
High confidence in the explanation based on source reliability and timing.